Medicine and Dentistry
Antifungal Agent
100%
Imidazole
100%
Vagina Candidiasis
100%
Oral Candidiasis
100%
Antifungal Therapy
100%
Triazole
100%
Health Care Cost
36%
Intravaginal Administration
27%
Adverse Event
18%
Sexually Transmitted Disease
18%
Patient Preference
18%
Cost-Effectiveness Analysis
9%
Human Immunodeficiency Virus
9%
Randomized Controlled Trial
9%
Diabetes Mellitus
9%
Health Service
9%
Breast Feeding
9%
Clinical Significance
9%
Contraindication
9%
Random Effects Model
9%
Odds Ratio
9%
Nursing and Health Professions
Vagina Candidiasis
100%
Antifungal Agent
100%
Thrush
100%
Imidazole
100%
Triazole
100%
Antifungal Therapy
100%
Intravaginal Drug Administration
27%
Adverse Event
18%
Sexually Transmitted Disease
18%
Patient Preference
18%
Human Immunodeficiency Virus
9%
Cost Effectiveness Analysis
9%
Odds Ratio
9%
Cochrane Library
9%
Diabetes Mellitus
9%
Health Service
9%
Contraindication
9%
Breast Feeding
9%
Pharmacology, Toxicology and Pharmaceutical Science
Imidazole
100%
Antifungal Agent
100%
Vagina Candidiasis
100%
Thrush
100%
Triazole
100%
Intravaginal Administration
23%
Adverse Event
15%
Sexually Transmitted Disease
15%
Route of Administration
7%
Randomized Controlled Trial
7%
Diabetes Mellitus
7%
HIV
7%
Random Effects Model
7%